?酸性神经鞘磷脂酶抗体Quantity size:
0.2ml
Concentration:
1mg/ml Buffer = 0.01M TBS(pH7.4) with 1% BSA, 0.03% Proclin300 and 50% Glycerol.
Background:
Converts sphingomyelin to ceramide. Also has phospholipase C activities toward 1,2-diacylglycerolphosphocholine and 1,2-diacylglycerolphosphoglycerol. Isoform 2 and isoform 3 have lost catalytic activity.
Involvement in disease: Defects in SMPD1 are the cause of Niemann-Pick disease type A (NPDA) ; 酸性神经鞘磷脂酶抗体also known as Niemann-Pick disease classical infantile form. It is an early-onset lysosomal storage disorder caused by failure to hydrolyze sphingomyelin to ceramide. It results in the accumulation of sphingomyelin and other metabolically related lipids in reticuloendothelial and other cell types throughout the body, leading to cell death. Niemann-Pick disease type A is a primarily neurodegenerative disorder characterized by onset within the first year of life, mental retardation, 酸性神经鞘磷脂酶抗体digestive disorders, failure to thrive, major hepatosplenomegaly, and severe neurologic symptoms. The severe neurological disorders and pulmonary infections lead to an early death, often around the age of four. Clinical features are variable. A phenotypic continuum exists between type A (basic neurovisceral) and type B (purely visceral) forms of Niemann-Pick disease, and the intermediate types encompass a cluster of variants combining clinical features of both types A and B.
酸性神经鞘磷脂酶抗体Also known as:
Acid sphingomyelinase; ASM; ASM_HUMAN; aSMase; NPD; Smpd1; Sphingomyelin phosphodiesterase 1 acid lysosomal; Sphingomyelin phosphodiesterase.
Specificity:
●
Rabbit Polyclonal IgG, affinity purified by Protein A.
●
Reacts with: Human, Mouse, Rat, Dog, Pig, Cow, Rabbit, .
●
酸性神经鞘磷脂酶抗体Immunogen: KLH conjugated synthetic peptide derived from human Acid sphingomyelinase.
●
Predicted Molecular Weight: 64kDa.
Storage:
Shipped at 4℃, Store at -20℃ (Avoid repeated freeze/thaw cycles).
Application:
WB=1:100-500 ELISA=1:500-1000 IHC-P=1:100-500 IHC-F=1:100-500 ICC=1:100-500 IF=1:100-500
Not yet tested in other applications.
Optimal working dilutions must be determined by the end user.
kl963Ge01别孕烯醇酮(AP)多克隆抗体Polyclonal Antibody to Allopregnanolone (AP)
kl519Rb51载脂蛋白A1(APOA1)多克隆抗体Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl519Po01载脂蛋白A1(APOA1)多克隆抗体Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl519Bo01载脂蛋白A1(APOA1)多克隆抗体Polyclonal Antibody to Apolipoprotein A1 (APOA1)
kl604Si01载脂蛋白A2(APOA2)多克隆抗体Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl604Po01载脂蛋白A2(APOA2)多克隆抗体Polyclonal Antibody to Apolipoprotein A2 (APOA2)
kl603Rb51载脂蛋白B100(APOB100)多克隆抗体Polyclonal Antibody to Apolipoprotein B100 (APOB100)
kl930Po01脱铁转铁蛋白(apoTf)多克隆抗体Polyclonal Antibody to Apotransferrin (apoTf)
kl023Po01β-乳球蛋白(βLg)多克隆抗体Polyclonal Antibody to Beta-Lactoglobulin (bLg)
kl876Hu01降钙素基因相关肽(CGRP)多克隆抗体Polyclonal Antibody to Calcitonin Gene Related Peptide (CGRP)
kl876Mu01降钙素基因相关肽(CGRP)多克隆抗体Polyclonal Antibody to Calcitonin Gene Related Peptide (CGRP)
kl876Ra01降钙素基因相关肽(CGRP)多克隆抗体Polyclonal Antibody to Calcitonin Gene Related Peptide (CGRP)
kl087Ge01几丁质酶(CTS)多克隆抗体Polyclonal Antibody to Chitinase (CTS)
kl374Hu01几丁质酶1(CHIT1)多克隆抗体Polyclonal Antibody to Chitinase 1 (CHIT1)
kl374Mu01几丁质酶1(CHIT1)多克隆抗体Polyclonal Antibody to Chitinase 1 (CHIT1)
kl374Ra01几丁质酶1(CHIT1)多克隆抗体Polyclonal Antibody to Chitinase 1 (CHIT1)
kl701Ge01胆固醇(CH)多克隆抗体Polyclonal Antibody to Cholesterol (CH)
kl088Ge01胆酸(CA)多克隆抗体Polyclonal Antibody to Cholic Acid (CA)
kl086Bo01糜蛋白酶(CTR)多克隆抗体Polyclonal Antibody to Chymotrypsin (CTR)
kl309Hu01糜蛋白酶样蛋白(CTRL)多克隆抗体Polyclonal Antibody to Chymotrypsin Like Protein (CTRL)
更多
企业名称
上海康朗生物科技有限公司
企业信息已认证
企业类型
信用代码
310112001510759
成立日期
2015-05-29
注册资本
100
经营范围
从事生物科技技术领域内技术开发、技术咨询、技术服务、技术转让,实验分析仪器、化工产品及原料(除危险化学品、监控化学品、烟花爆竹、民用爆竹物品、易制毒化学品)、仪器仪表、环保设备、酒店用品、皮革制品、床上用品、电子产品的销售。【依法须经批准的项目,经相关部门批准后方可开展经营活动】
上海康朗生物科技有限公司
公司地址
上海市闵行区闵北路88弄1-30号第22栋BV145室
客服电话